Basic research for oral cancer therapy by anti-cancer drugs and apoptosis-inducing factor
Basic research for oral cancer therapy by anti-cancer drugs and apoptosis-inducing factor
批准号:
09557171
负责人:
NAGUMO Masao
金额:
$7.04万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
我们研究了抗癌药物(CDDP、5-Fu)、IFN-γ或NO供体(SNP、SNAP、NOC)对主要在从舌鳞状细胞癌建立的NA细胞中诱导凋亡的影响。进一步研究这些药物对NA细胞中c-myc和c-myb表达、粘附分子ICAM-1、Fas/Fas配体和可溶性Fas的影响。主要研究结果如下:1. NO供体诱导NA细胞凋亡,同时抑制c-myc和c-myb mRNA的表达. CDDP和5-Eu可诱导NA细胞凋亡,提示FLICE(caspase 8)可能参与了诱导NA细胞凋亡的过程。然而,当NA细胞与这些抗癌药物一起处理时,没有观察到协同效应。CDDP和5- Eu均能促进NA细胞ICAM-1的表达,CDDP和5-Eu联合作用对ICAM-1的诱导有协同作用。当用IEN-γ或抗Fas抗体(CH 11)处理NA细胞时,诱导凋亡。细胞膜结合Fas无明显变化,而细胞培养液中可溶性Eas减少.用IFN-γ或TNF-α处理HL-60细胞后,HL-60细胞表面Fas和Fas配体的表达增强,bcl-2蛋白及其mRNA的表达降低,表明抗肿瘤药物或NO供体均可诱导细胞凋亡,IFN-γ或TNF-α可增强细胞凋亡的诱导作用。
英文摘要
We investigated the effects of anti-cancer drugs (CDDP, 5-Fu) , IFN-y or NO donors(SNP, SNAP, NOC) on induction of apoptosis mainly in NA cells which had been established from a squamous cell carcinoma of the tongue. Further the effects of these agents on the expression of c-myc and c-myb, adhesion molecules including ICAM-1, Fas/Fas ligand, and soluble Fas were also studied in NA cells. The results obtained were as follows :1. When NA cells were treated with NO donors, apoptosis of NA cells was induced together with the inhibition of the expression of c-myc and c-myb mRNA.2. CDDP and 5-Eu induced apoptosis of NA cells and it was suggested that FLICE (caspase 8) might be concerned in the induction of apoptosis of NA cells. However, synergistic -effect was not observed when NA cells were treated both with these anti-cancer drugs.3. ICAM-1 expression on NA cells was enhanced by the treatment of CDDP or 5- Eu, and simultaneous treatment with CDDP and 5-Eu exhibited synergistic effect on the induction of ICAM-1.4. Apoptosis was induced when NA cells were treated with IEN-gamma or anti-Fas antibody (CH11). Then, membrane binding Fas was not altered, whereas soluble Eas in the medium was decreased.5. The expression of Fas and Fas ligand on HL-60 cells, a leukemia cell line, was enhanced by the treatment with IEN-gamma or TNF-alpha, while the expression of bcl-2 protein and its mRNA was reduced by the treatment.These results indicate that apoptosis is induced both by anti-cancer drugs or NO donors and that the induction of apoptosis is enhanced by IFN-gamma or TNF-alpha.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
滝沢邦生 他: "cisplatin, s-flaorourocil併用による癌細胞の細胞接着因子発現誘導とT細胞の抗腫瘍効果誘導" Proceding of the Japanese Cancer Association (56th Annual Meeting). 88(Sup). 375-375 (1997)
Kunio Takizawa 等:“联合使用顺铂和 s-flaorourocil 诱导癌细胞中的细胞粘附因子表达和诱导 T 细胞的抗肿瘤作用”日本癌症协会会议记录(第 56 届年会)88(Sup)。 375-375(1997)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takizawa K.et al: "Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorounacil in a cancer cell line via a NF-κB independent pathuay" Brit Journal of Cancer. (in press). (1999)
Takizawa K. 等人:“顺铂和 5-氟尿嘧啶通过 NF-κB 独立途径协同诱导癌细胞系中的 ICAM-1 表达”(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ohashi M.et al: "Upregulation of Fos/Fasligand expression by IFN-γ_<61> TNF-α on HL-60 cells" Molecular Biology of the Cell.8. 249-249 (1997)
Ohashi M.等人:“HL-60细胞上IFN-γ_61TNF-α对Fos/Fas配体表达的上调”《细胞分子生物学》249-249(1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takizawa K.et al: "Induction of soluble Fas release from cancer cells by inteferon-γ" Molecular Biology of the cell.8. 248-248 (1997)
Takizawa K.等人:“干扰素-γ诱导癌细胞释放可溶性Fas”细胞分子生物学。8。8。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takizawa K,et al: "Induction of socuble Fosrelease from cancercells by interferox-r" Molecular Biology of the Call.8. 248-248 (1997)
Takizawa K,et al:“Induction of socuble Fosrelease from cancercells by interferox-r”分子生物学的 Call.8。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 22 条
Prediction of malignant transformation of oral precancerous lesions by analyzing gene expression profiles and gene polymorphism.
-
批准号:15209070
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$25.71万
-
财政年份:2003
-
负责人:NAGUMO Masao
-
依托单位:
The participation of p53 independent pathway in the process of oral carcinogenesis
-
批准号:13470439
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.43万
-
财政年份:2001
-
负责人:NAGUMO Masao
-
依托单位:
The effects of CDK inhibitors and PI3 kinase related kinase on the carcinogenesis from precancerous lesions
-
批准号:11470443
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.45万
-
财政年份:1999
-
负责人:NAGUMO Masao
-
依托单位:
Development of detection method of metastasis from squamous cell carcinoma of head and neck using peripheral blood
-
批准号:11557163
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$7.68万
-
财政年份:1999
-
负责人:NAGUMO Masao
-
依托单位:
Cell cycle and apoptosis in the process of carcinogenesis in oral precancerous lesions
-
批准号:08457554
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.86万
-
财政年份:1996
-
负责人:NAGUMO Masao
-
依托单位:
Apoptosis in the process of carcinogenesis of oral precancerous lesions
-
批准号:06454572
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.1万
-
财政年份:1994
-
负责人:NAGUMO Masao
-
依托单位:
Changes of cytokines and their gene expression in the process of carcinogenesis of oral precancerous lesions
-
批准号:04454511
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.97万
-
财政年份:1992
-
负责人:NAGUMO Masao
-
依托单位:
Studies of IFN, IL-1, and Tnf on Induction of Differentiation and Activation of Neutrophils.
-
批准号:63480448
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.65万
-
财政年份:1988
-
负责人:NAGUMO Masao
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RNF181通过稳定FGF2蛋白表达促进胃癌5-FU耐药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:姜苏婷
-
依托单位:
NSUN6通过调控PFKFB3促进糖酵解在结直肠癌5-Fu耐药中的作用和分子机制研究
-
批准号:MS25H160112
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:薛猛
-
依托单位:
ITGA4、ITGB6在逆转结直肠癌5-FU耐药中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陈燕
-
依托单位:
NUSAP1-PRMT5蛋白复合体调控胃癌5-FU耐药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王锋
-
依托单位:
紫草素下调PKM2抑制MER11乳酸化阻断同源重组克服胃癌5-FU耐药的机制研究
-
批准号:2025JJ60655
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:张准
-
依托单位:
Lactobacillus reuteri调控FTO/CMPK2/NLRP3信号轴介导炎症反应治疗5-FU诱导的口腔粘膜炎的作用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邱敬诚
-
依托单位:
2-AAPA抑制m6A阅读蛋白IGF2BP3下调TGM2 mRNA稳定性逆转结肠癌5-FU耐药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:莫佳萍
-
依托单位:
基于黑磷/5-FU的个性化药物递送系统在皮肤癌协同治疗中的应用
-
批准号:
-
项目类别:省市级项目
-
资助金额:30.0万元
-
批准年份:2024
-
负责人:邵俊东
-
依托单位:
PPAR-α调控SCD1介导脂代谢重编程导致结肠癌5-FU耐药和机制研
究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李艳
-
依托单位:
核仁和纺锤体相关蛋白NUSAP1 促进胃癌细胞5-FU耐药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:王锋
-
依托单位: